Trou­bled Aveo hit with an­oth­er set­back as in­ves­ti­ga­tors shut­ter PhII

Aveo On­col­o­gy may be un­der new man­age­ment, but it’s still af­flict­ed by a long-run­ning pat­tern of trou­ble in the clin­ic. Usu­al­ly, that trou­ble has been …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA